c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoterGUOCHUN JIANG; ESPESETH, Amy; HAZUDA, Daria J et al.Journal of virology. 2007, Vol 81, Num 20, pp 10914-10923, issn 0022-538X, 10 p.Article

Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural productsSINGH, Sheo B; ONDEYKA, John G; SCHLEIF, William A et al.Journal of natural products (Print). 2003, Vol 66, Num 10, pp 1338-1344, issn 0163-3864, 7 p.Article

Isolation, structure, and HIV-1 integrase inhibitory activity of cytosporic acid, a fungal metabolite produced by a Cytospora spJAYASURIYA, Hiranthi; ZIQIANG GUAN; POLISHOOK, Jon D et al.Journal of natural products (Print). 2003, Vol 66, Num 4, pp 551-553, issn 0163-3864, 3 p.Article

Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitorsARCHIN, Nancie M; KEEDY, Kara S; ESPESETH, Amy et al.AIDS (London). 2009, Vol 23, Num 14, pp 1799-1806, issn 0269-9370, 8 p.Article

A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 ExpressionKEEDY, Kara S; ARCHIN, Nancie M; GATES, Adam T et al.Journal of virology. 2009, Vol 83, Num 10, pp 4749-4756, issn 0022-538X, 8 p.Article

A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A backgroundGRAHAM, Donald J; STAHLHUT, Mark; FLORES, Osvaldo et al.Antiviral research. 2006, Vol 69, Num 1, pp 24-30, issn 0166-3542, 7 p.Article

Analysis of Low-Frequency Mutations Associated with Drug Resistance to Raltegravir before Antiretroviral TreatmentJIA LIU; MILLER, Michael D; DANOVICH, Robert M et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 3, pp 1114-1119, issn 0066-4804, 6 p.Article

Antiviral Activity and In Vitro Mutation Development Pathways of MK-6186, a Novel Nonnucleoside Reverse Transcriptase InhibitorMEIQING LU; FELOCK, Peter J; WILLIAMS, Theresa M et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3324-3335, issn 0066-4804, 12 p.Article

Structural Basis for the Inhibition of RNase H Activity of HIV-1 Reverse Transcriptase by RNase H Active Site-Directed InhibitorsSU, Hua-Poo; YOUWEI YAN; GROBLER, Jay A et al.Journal of virology. 2010, Vol 84, Num 15, pp 7625-7633, issn 0022-538X, 9 p.Article

Dihydroxypyridopyrazine -1,6 -dione HIV-1 integrase inhibitorsWAI, John S; KIM, Boyoung; HAZUDA, Daria J et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 20, pp 5595-5599, issn 0960-894X, 5 p.Article

Isolation, structure, absolute stereochemistry, and HIV-1 integrase inhibitory activity of integrasone, a novel fungal polyketideHERATH, Kithsiri B; JAYASURIYA, Hiranthi; BILLS, Gerald F et al.Journal of natural products (Print). 2004, Vol 67, Num 5, pp 872-874, issn 0163-3864, 3 p.Article

Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase InhibitorLAI, Ming-Tain; MUNSHI, Vandna; TOUCH, Sinoeun et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2424-2431, issn 0066-4804, 8 p.Article

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 InfectionCOOPER, David A; STEIGBIGEL, Roy T; SCHECHTER, Mauro et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 355-365, issn 0028-4793, 11 p.Article

Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemiaPEK YEE LUM; HE, Yudong D; ADAMSON, Gary E et al.Genomics (San Diego, Calif.). 2007, Vol 90, Num 4, pp 464-473, issn 0888-7543, 10 p.Article

Discovery of oxadiazoyl tertiary carbinamine inhibitors of β-secretase (BACE-1)RAJAPAKSE, Hemaka A; MANTERMET, Philippe G; COLUSSI, Dennis et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 25, pp 7270-7273, issn 0022-2623, 4 p.Article

Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic SystemBROWN, Ashley N; MCSHARRY, James J; ADAMS, Jonathan R et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1170-1181, issn 0066-4804, 12 p.Article

Distinct Mutation Pathways of Non-Subtype B HIV-1 during In Vitro Resistance Selection with Nonnucleoside Reverse Transcriptase InhibitorsLAI, Ming-Tain; MEIQING LU; WILLIAMS, Theresa M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 11, pp 4812-4824, issn 0066-4804, 13 p.Article

Rapid P1 SAR of brain penetrant tertiary carbinamine derived BACE inhibitorsHONG ZHU; YOUNG, Mary B; TUGUSHEVA, Katherine et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 5, pp 1779-1782, issn 0960-894X, 4 p.Article

A potent and orally active HIV-1 integrase inhibitorEGBERTSON, Melissa S; MORITZ, H. Marie; WALLACE, Audrey et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 5, pp 1392-1398, issn 0960-894X, 7 p.Article

Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assayLUDMERER, Steven W; GRAHAM, Donald J; LAFEMINA, Robert L et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 5, pp 2059-2069, issn 0066-4804, 11 p.Article

Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaquesHAZUDA, Daria J; YOUNG, Steven D; DORNADULA, Geethanjali et al.Science (Washington, D.C.). 2004, Vol 305, Num 5683, pp 528-532, issn 0036-8075, 5 p.Article

Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffoldWILLIAMS, Peter D; STAAS, Donnette D; ECTO, Linda T et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 22, pp 6754-6757, issn 0960-894X, 4 p.Article

10-Hydroxy-7,8-dihydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-diones : Potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutantsWISCOUNT, Catherine M; WILLIAMS, Peter D; VACCA, Joseph P et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 16, pp 4581-4583, issn 0960-894X, 3 p.Article

Raltegravir with Optimized Background Therapy for Resistant HIV-1 InfectionSTEIGBIGEL, Roy T; COOPER, David A; KATLAMA, Christine et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 339-354, issn 0028-4793, 16 p.Article

8 -Hydroxy -3,4 -dihydropyrrolo[1,2 -a]pyrazine -1 (2H) -one HIV-1 integrase inhibitorsFISHER, Thorsten E; KIM, Boyoung; GABRYELSKI, Lori J et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 23, pp 6511-6515, issn 0960-894X, 5 p.Article